Related projects
Discover more projects across a range of sectors and discipline — from AI to cleantech to social innovation.
Expression of variant SARS-CoV-2 spike proteins for antiviral development
The virus spike receptor has been used to successful generate vaccine candidates for SARS-CoV-2 infections. Furthermore, disruption of the virus interacting with host cells represents a viable options for antiviral development. We will express both the viral spike protein and host ACE2 receptor for development of vaccine and antivirals.
Faculty Supervisor:
M. Joanne Lemieux
Student:
Partner:
Applied Pharmaceutical Innovation
Discipline:
Life Sciences
Sector:
Professional, scientific and technical services; Retail trade
University:
University of Alberta
Program:
Accelerate
Current openings
Find the perfect opportunity to put your academic skills and knowledge into practice!
Find Projects
International
Load More
International
Load More
